Drug reactions and desensitization in AIDS

Immunology and Allergy Clinics of North America

Volumn 17, Issue 2, 1997, Pages 319-338

  Beall, G ^a   Sanwo, M ^a   Hussain, H ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ATOVAQUONE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; DELAVIRDINE; FANSIDAR; NEVIRAPINE; PENTAMIDINE; PROBENECID; RIFAMPICIN; SULFADIAZINE; THALIDOMIDE; THIOACETAZONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DESENSITIZATION; FEVER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; RASH; REVIEW;

EID: 0030957126     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(05)70309-X     Document Type: Review

References (72)

1. N. Absar H. Daneshvar G. Beall Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients J Allergy Clin Immunol 93 1994 1001 1005
2. N.J. Attaway Familial drug allergy J Allergy Clin Immunol 87 1991 227
3. M.K. Battegay M. Opravil B. Wuthrich Rash with amoxicillin-clavulanate therapy in HIV-infected patients [letter] Lancet 2 1989 1100
4. C.G. Baum J.A. Sonnabend M. O'Sullivan Prophylaxis of AIDS-related Pneumocystis carinii pneumonia with aerosolized pentamidine in a patient with hypersensitivity to systemic pentamidine J Allergy Clin Immunol 90 1990 268 269
5. Beardsell AD, Coker K, Woodfall B, et al: Cotrimoxazole (TMP-SMX) desensitization using adjunctive steroid therapy in HIV/AIDS patients [abstract Tu.B.414]. Scientific Program of XI International Conference on AIDS, Vancouver, BC, Canada, 1996
6. M.G. Beaumont A. Graziani P.A. Ubel Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immune deficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole Am J Med 100 1996 611 616
7. T.G. Berger J.W. Tappero G.S. Leoung Aerosolized pentamidine and cutaneous eruptions Ann Intern Med 110 1989 1035 1036
8. M. Bigby S. Jick H. Jick Drug-induced cutaneous reactions: A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975–1982 JAMA 256 1986 3358 3363
9. A. Carr A. Gross D.A. Cooper Acetylation phenotypes and hypersensitivity (HS) to trimethoprim-sulphamethoxazole (TMP-SMX) in HIV-infected patient [abstract TC11] Annu Conf Australias Soc HIV Med 5 1993 31
10. A. Carr R. Penny D.A. Cooper Allergy and desensitization to zidovudine in patients with acquired immunodeficiency syndrome (AIDS) J Allergy Clin Immunol 91 1993 683 685
11. A. Carr R. Penny D.A. Cooper Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients AIDS 7 1993 65 71
12. A. Carr C. Swanson R. Penny Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS J Infect Dis 167 1993 180 185
13. A. Carr B. Tindall R. Penny Patterns of multiple-drug hypersensitivities in HIV-infected patients AIDS 7 1993 1532 1533
14. A. Carr B. Tindall R. Penny In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV Clin Exp Immunol 94 1993 21 25
15. E. Caumes H. Bocquet G. Guermonprez Adverse cutaneous reactions to pyrimethamine/sulfadiazine and pyrimethamine/clindamycin in patients with AIDS and toxoplasma encephalitis Clin Infect Dis 21 1995 656 658
16. R.E. Chaisson G.F. Schecter C.P. Theuer Tuberculosis in patients with the acquired immunodeficiency syndrome: Clinical features, response to therapy, and survival Am Rev Respir Dis 136 1987 570 574
17. P. Chalasani H. Baffoe-Bonnie R.L. Jurado Dapsone therapy causing sulfone syndrome and lethal hepatic failure in an HIV-infected patient South Med J 87 1994 1143 1144
18. P. Chanez J. Bousquet J.M. Mauboussin Bronchoconstriction and pentamidine Lancet 1 1989 1335 1336
19. J.A. Cohn A. McMeeking W. Cohen Evaluation of the policy of empiric treatment of suspected toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome Am J Med 86 1989 521 527
20. S.A. Cooperman R.A. Johnson R. Platt Cutaneous disease and drug reactions in HIV infection N Engl J Med 328 1993 1670 1674
21. B. Dannemann J.A. McCutchan D. Israelski Treatment of toxoplasmic encephalitis in patients with AIDS Ann Intern Med 116 1992 33 43
22. R.L. Deamer J.G. Prichard G.J. Loman Hypersensitivity and anaphylactoid reactions to ciprofloxacin Ann Pharmacother 26 1992 1081 1084
23. B. de la Hoz Caballer M. Fernandez-Rivas Management of sulfadiazine allergy in patients with acquired immunodeficiency syndrome J Allergy Clin Immunol 88 1991 137 138
24. P.M. Girard R. Landman C. Gaudebout Dapsone–pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection N Engl J Med 328 1993 1514 1520
25. F.M. Gordin G.L. Simon C.B. Wofsy Adverse reactions to trimethoprim-sulfamethoxazole in patients with acquired immunodeficiency syndrome Ann Intern Med 100 1984 495 499
26. Haslett PAJ, Tramontana JM, Burroughs M, et al: An evaluation of the safety and toxicities of thalidomide in HIV-1 infected individuals [abstract Th.B.170]. Scientific Program of XI International Conference on AIDS, Vancouver, 1996
27. R.E. Henry J.A. Wegmann J.E. Hartle Successful oral acyclovir desensitization Ann Allergy 70 1993 386 388
28. C.L. Holland C. Malasky A. Ogunkoya Rapid oral desensitization to isoniazid and rifampin Chest 98 1990 1518 1519
29. O. Idsoe T. Guthe R.R. Willcox Nature and extent of penicillin side reactions, with particular reference to fatalities from anaphylactic shock Bull WHO 38 1968 159 188
30. M.A. Jacobson C.L. Besch C. Child Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis Lancet 339 1992 333 334
31. M.A. Jacobson M.S. McGrath P. Joseph Zidovudine induced fever J Acquir Immune Defic Syndr 2 1989 382 388
32. J.W. Kelly D.P. Dooley C.P. Lattuada A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus Clin Infect Dis 14 1992 1034 1039
33. P.P. Koopmans A.J.A.M. van der Ven T.B. Vree Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: Allergic or toxic? AIDS 9 1995 217 222
34. Koopmans PP, van der Ven A, Vree T, et al: Drug reactions to co-trimoxazole in HIV infection possibly not due to hydroxylamine [abstract Mo.B.1193]. Scientific Program of XI International Conference on AIDS, Vancouver, BC, Canada, 1996
35. J.A. Kovacs J.W. Hiemenz A.M. Macher Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies Ann Intern Med 100 1984 663 671
36. K.L. Lanctot B.M. Ghajar N.H. Shear Improving the diagnosis of hypersensitivity reactions associated with sulfonamides J Clin Pharmacol 34 1994 1228 1233
37. C.L.S. Leen B.K. Mandal Rash due to nebulized pentamidine Lancet 2 1988 1250 1251
38. C. Leport F. Raffi S. Matheron Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome Am J Med 84 1988 94 100
39. S. Lori Sulfonamide allergies—management in the nineties Allergy Clin Immunol Internat 8 1996 5
40. B.J. Luft R. Hafner A.H. Korzun Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome N Engl J Med 329 1993 995 100
41. C. Marcos B. Spoena I. Luna Clindamycin desensitization in an AIDS patient AIDS 9 1995 1201 1202
42. G.J. Martin S.F. Paparello C.F. Decker A severe systemic reaction to trimethoprim-sulfamethoxazole in a patient infected with the human immunodeficiency virus Clin Infect Dis 16 1993 175 176
43. J. Matz L.C. Borish J.M. Routes Oral desensitization to rifampin and ethambutol in mycobacterial disease Am J Respir Crit Care Med 149 1994 815 817
44. D. Mauri-Hellweg F. Bettens D. Mauri Activation of drug-specific CD4+ and CD8+ or T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine J Immunol 155 1995 462 472
45. G.F. McKinley D.S. Mazza M.H. Grieco Urticarial reaction to zidovudine [letter] Lancet 1 1990 384
46. I. Medina J. Mills G. Leoung Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone N Engl J Med 323 1990 776 782
47. C.E. Metroka N.J. Lewis D.P. Jacobus Desensitization to dapsone in HIV-positive patients [letter] JAMA 267 1992 512
48. R. Mitsuyasu J. Groopman P. Volberding Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma [letter] N Engl J Med 308 1983 1535 1536
49. J.N. Moreno R.B. Poblete C. Maggio Rapid oral desensitization for sulfonamides in patients with the acquired immunodeficiency syndrome Ann Allergy Asthma Immunol 74 1995 140 146
50. T.R. Navin R.E. Fontaine Intravenous versus intramuscular administration of pentamidine [letter] N Engl J Med 311 1984 1701 1702
51. M.-T. Nguyen P.J. Weiss M.R. Wallace Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients AIDS 9 1995 573 575
52. P. Nunn D. Kibuga S. Gathua Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis Lancet 337 1991 627 630
53. A. Okwera C. Whalen F. Byekwaso Randomized trial of thiacetazone and rifampin-containing regimens for pulmonary tuberculosis in HIV-infected Ugandans Lancet 344 1994 1323 1328
54. O'Neill WM, Tsoukas CM, Gilfix BM, et al: Distribution of NAT2 phenotype in HIV+/AIDS patients [abstract Pub.B.1081]. Scientific Program of XI International Conference on AIDS, Vancouver, BC, Canada, 1996
55. R. Patterson P.A. Greenberger Management of drug allergy in patients with acquired immunodeficiency syndrome J Allergy Clin Immunol 79 1987 484 488
56. D.M. Porteous T.G. Berger Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection [letter] Arch Dermatol 127 1991 740 741
57. M.J. Rieder R. Krause I.A. Bird Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected and noninfected cells J Acquir Immune Defic Syndr Hum Retrovirol 8 1995 134 140
58. C. Roudier E. Caumes O. Rogeauz Adverse cutaneous reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia Arch Dermatol 130 1994 1383 1386
59. J. Ruskin M. LaRiviere Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease Lancet 337 1991 468 471
60. P. Saiag E. Caumes O. Chosidow Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus J Am Acad Dermatol 26 1992 567 574
61. M.C. Sanwo R. Nwadiuko G.N. Beall IVIG in severe drug reactions J Allergy Clin Immunol 98 1997 1112 1115
62. M.C. Sanwo M.D. Witt G.N. Beall Rapid oral desensitization to clindamycin in a patient with Toxoplasma encephalitis and the acquired immunodeficiency syndrome [abstract] Ann Allergy Asthma Immunol 74 1995 84
63. F.R. Sattler R. Cowan D.M. Nielsen Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome Ann Intern Med 109 1988 280 287
64. A. Saxon G. Beall A. Rohr Immediate hypersensitivity reactions to beta lactam antibiotics Ann Intern Med 107 1987 204
65. R.W. Shafer P.A. Seitzman M.L. Tapper Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions J Acquir Immune Defic Syndr 2 1989 389 393
66. Skiest DJ, Keiser P: Significance of peripheral eosinophilia in HIV infected individuals [abstract Mo.B.1279]. Scientific Program of XI International Conference on AIDS, Vancouver, 1996
67. P.M. Small G.F. Schecter P.C. Goodman Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection N Engl J Med 324 1991 289 294
68. J.J. Stavola G.J. Noel Efficacy and safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus–infected children Pediatr Infec Dis J 12 1993 644 647
69. M. Tenant-Flowers M.J. Boyle D. Carey Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis AIDS 5 1991 311 315
70. S. Walmsley C. Levinton J. Brunton A multicenter randomized double-blind placebo-controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome J Acquir Immune Defic Syndr 8 1995 345 347
71. D.N. Wright R.P. Nelson D.K. Ledford Serum IgE and human immunodeficiency virus (HIV) infection J Allergy Clin Immunol 85 1990 445
72. R.M. Wurtz D. Abrams S. Becker Anaphylactoid drug reactions to ciprofloxacin and rifampicin in HIV-infected patients Lancet 1 1989 955 956